Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights

Abstract Leishmaniasis is one of the infectious diseases caused by protozoa and is considered the second most significant parasitic disease after malaria. In this research, thiosemicarbazone Schiff base derivatives were synthesized via a one-pot, two-step, three-component reaction. Then, the effecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Soheila Molaei, Jafar Abbasi Shiran, Neda Shakour, Majid Baradaran, Zahra Malihi, Mohammad Reza Rahimi, Yasamin Abedini Zal, Saghi Sepehri
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-10545-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849766922506207232
author Soheila Molaei
Jafar Abbasi Shiran
Neda Shakour
Majid Baradaran
Zahra Malihi
Mohammad Reza Rahimi
Yasamin Abedini Zal
Saghi Sepehri
author_facet Soheila Molaei
Jafar Abbasi Shiran
Neda Shakour
Majid Baradaran
Zahra Malihi
Mohammad Reza Rahimi
Yasamin Abedini Zal
Saghi Sepehri
author_sort Soheila Molaei
collection DOAJ
description Abstract Leishmaniasis is one of the infectious diseases caused by protozoa and is considered the second most significant parasitic disease after malaria. In this research, thiosemicarbazone Schiff base derivatives were synthesized via a one-pot, two-step, three-component reaction. Then, the effectiveness of the compounds against the two forms of Leishmania major and Leishmania tropica called amastigote and promastigote, was tested. All synthesized compounds displayed weak to good anti-amastigote and anti-promastigote activities. Notably, compounds 5g and 5p were the most potent compounds against amastigote and promastigote forms, respectively, of Leishmania major, with IC50 = 26.7 µM and 12.77 µM. Analogues 5e and 5g were the most potent compounds against amastigote and promastigote forms of Leishmania tropica, with IC50 = 92.3 µM and 12.77 µM, respectively. The cytotoxicity activity of the compounds was also evaluated using the J774.A1 cell lines. Some of the screened derivatives displayed low cytotoxicity to macrophage infection. Among compounds, 5p and 5e showed the highest SI (95.4 and 34.6) against L. major and L. tropica, respectively. In the next phase, the most effective thiosemicarbazone derivatives were examined for their ability to induce apoptosis in promastigotes. According to the results, these compounds displayed different early and late apoptosis as well as necrotic effects on promastigotes of Leishmania major and Leishmania tropica. Furthermore, the compounds’ drug-likeness and pharmacokinetic parameters were predicted in silico. All compounds showed acceptable drug-likeness and pharmacokinetic profiles. Furthermore, the most likely sites of the compounds metabolized by the major cytochromes were identified. Additionally, the in silico compounds’ cardiotoxicity potential was assessed. This investigation showed compounds 5m-p were cardiotoxic. Lastly, molecular docking and molecular dynamics simulations were performed to explore the potential mechanisms of anti-leishmanial activity in the LmPRT1 active site.
format Article
id doaj-art-e15bc1deaea345f184e6587c9259ea30
institution DOAJ
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e15bc1deaea345f184e6587c9259ea302025-08-20T03:04:25ZengNature PortfolioScientific Reports2045-23222025-07-0115113710.1038/s41598-025-10545-6Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insightsSoheila Molaei0Jafar Abbasi Shiran1Neda Shakour2Majid Baradaran3Zahra Malihi4Mohammad Reza Rahimi5Yasamin Abedini Zal6Saghi Sepehri7Zoonoses Research Center, Ardabil University of Medical SciencesPharmaceutical Sciences Research Center, Ardabil University of Medical SciencesDepartment of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical SciencesDepartment of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical SciencesDepartment of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical SciencesStudents Research Committee, School of Pharmacy, Ardabil University of Medical SciencesStudents Research Committee, School of Pharmacy, Ardabil University of Medical SciencesPharmaceutical Sciences Research Center, Ardabil University of Medical SciencesAbstract Leishmaniasis is one of the infectious diseases caused by protozoa and is considered the second most significant parasitic disease after malaria. In this research, thiosemicarbazone Schiff base derivatives were synthesized via a one-pot, two-step, three-component reaction. Then, the effectiveness of the compounds against the two forms of Leishmania major and Leishmania tropica called amastigote and promastigote, was tested. All synthesized compounds displayed weak to good anti-amastigote and anti-promastigote activities. Notably, compounds 5g and 5p were the most potent compounds against amastigote and promastigote forms, respectively, of Leishmania major, with IC50 = 26.7 µM and 12.77 µM. Analogues 5e and 5g were the most potent compounds against amastigote and promastigote forms of Leishmania tropica, with IC50 = 92.3 µM and 12.77 µM, respectively. The cytotoxicity activity of the compounds was also evaluated using the J774.A1 cell lines. Some of the screened derivatives displayed low cytotoxicity to macrophage infection. Among compounds, 5p and 5e showed the highest SI (95.4 and 34.6) against L. major and L. tropica, respectively. In the next phase, the most effective thiosemicarbazone derivatives were examined for their ability to induce apoptosis in promastigotes. According to the results, these compounds displayed different early and late apoptosis as well as necrotic effects on promastigotes of Leishmania major and Leishmania tropica. Furthermore, the compounds’ drug-likeness and pharmacokinetic parameters were predicted in silico. All compounds showed acceptable drug-likeness and pharmacokinetic profiles. Furthermore, the most likely sites of the compounds metabolized by the major cytochromes were identified. Additionally, the in silico compounds’ cardiotoxicity potential was assessed. This investigation showed compounds 5m-p were cardiotoxic. Lastly, molecular docking and molecular dynamics simulations were performed to explore the potential mechanisms of anti-leishmanial activity in the LmPRT1 active site.https://doi.org/10.1038/s41598-025-10545-6PromastigoteAmastigoteTropical diseaseApoptosisHydrazine-1-carbothioamide
spellingShingle Soheila Molaei
Jafar Abbasi Shiran
Neda Shakour
Majid Baradaran
Zahra Malihi
Mohammad Reza Rahimi
Yasamin Abedini Zal
Saghi Sepehri
Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights
Scientific Reports
Promastigote
Amastigote
Tropical disease
Apoptosis
Hydrazine-1-carbothioamide
title Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights
title_full Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights
title_fullStr Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights
title_full_unstemmed Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights
title_short Synthesis of thiosemicarbazone Schiff base derivatives as anti-leishmanial agents and molecular dynamics simulations insights
title_sort synthesis of thiosemicarbazone schiff base derivatives as anti leishmanial agents and molecular dynamics simulations insights
topic Promastigote
Amastigote
Tropical disease
Apoptosis
Hydrazine-1-carbothioamide
url https://doi.org/10.1038/s41598-025-10545-6
work_keys_str_mv AT soheilamolaei synthesisofthiosemicarbazoneschiffbasederivativesasantileishmanialagentsandmoleculardynamicssimulationsinsights
AT jafarabbasishiran synthesisofthiosemicarbazoneschiffbasederivativesasantileishmanialagentsandmoleculardynamicssimulationsinsights
AT nedashakour synthesisofthiosemicarbazoneschiffbasederivativesasantileishmanialagentsandmoleculardynamicssimulationsinsights
AT majidbaradaran synthesisofthiosemicarbazoneschiffbasederivativesasantileishmanialagentsandmoleculardynamicssimulationsinsights
AT zahramalihi synthesisofthiosemicarbazoneschiffbasederivativesasantileishmanialagentsandmoleculardynamicssimulationsinsights
AT mohammadrezarahimi synthesisofthiosemicarbazoneschiffbasederivativesasantileishmanialagentsandmoleculardynamicssimulationsinsights
AT yasaminabedinizal synthesisofthiosemicarbazoneschiffbasederivativesasantileishmanialagentsandmoleculardynamicssimulationsinsights
AT saghisepehri synthesisofthiosemicarbazoneschiffbasederivativesasantileishmanialagentsandmoleculardynamicssimulationsinsights